Opportunities for Collaboration Continue to Draw Independent Large and Small Practices From Across the Country

AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding

Lumpectomy Patients Received VeraForm® Marker and APBI Therapy for Breast Cancer Treatment

<p><i><strong>This press release replaces the release issued today at 9:15am EDT.</strong></i></p><p><i><strong>Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy.&nbsp;</strong></i></p><p><i><strong>Revealia&trade;: A Breakthrough in Cancer Detection through Advanced AI and Machine Learning</strong></i></p>

Data points to a broader industry-wide imaging accuracy crisis

New Kit Lets Vaccine Manufacturers Test 5′ Capping Efficiency at the Bench, With Answers in Less Than Two Hours

LungOI Is Among The First AI-based Tests To Receive a Medicare Payment Rate.

Wolchok joins the board having previously served as a juror with the foundation for the Vilcek Prizes for Creative Promise in Biomedical Science.

Investigators rapidly activate sites, expand trial reach, and achieve real-time data oversight with a complete and affordable cloud-based research imaging platform.

The new firm promises to bring a new model for a consulting partner in the life sciences industry.

Collaboration aims to advance pediatric oncology trial precision with the latest imaging technology.

Innovative pro-drug delivers superior efficacy with improved drug-like properties and safety profile

The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic stem cell transplantation (HSCT) for individuals with myelodysplastic syndromes (MDS) based on requests from ASH, ASTCT, NMDP, and CIBMTR.

Radiation Oncologist Dr. Sophia Edwards-Bennet talks one-on-one with Jim Masters on Soul Currency and The Path to Soul Immunity

LA Marathon Runners Take on 26.2 Miles to Support the Glioblastoma Foundation.

After years of successful collaboration, the esteemed organizations National Cancer Care Alliance (NCCA) and Quality Cancer Care Alliance (QCCA) have merged, culminating in the birth of a transformative new entity, ONCare Alliance, LLC.

Fast-growing innovator brings first-of-its-kind imaging ecosystem to clinical trials

ImageneOI is the first NSCLC genomic profiling AI tool on the Sectra Amplifier Marketplace.

The annual award honors Roberts’ special service to the patients and families that are served by the ASTCT community.

Global experts will share key insights to help healthcare professionals and researchers improve the lives of patients with blood-related disorders.

Genomate Health Inc, a global leader in precision oncology, announces its strategic partnership with Intelligene Healthcare Pvt Ltd, marking a significant step towards advancing personalized cancer care in India.

When We Tri(al) by TOUCH, The Black Breast Cancer Alliance has partnered with Carebox to provide Breasties, caregivers, and the entire Black community with an easy way to search and match to breast cancer clinical trials.

Pioneering Collaboration Unveils Charitable Lecture on Cutting-Edge Cancer Prevention

With a $500,000 grant from the GI Research Foundation to Dr. Osman Ahmed, UChicago Medicine will be one of only four hospitals using a new technique to noninvasively treat liver cancer.

Now patients, caregivers and healthcare professionals have an easy and effective way to search for and match with gastric cancer clinical trials.

With $3.5 million in funding from the GI Research Foundation, a team at the MD Anderson Cancer Center explores a one-two punch to combat BRAF-mutated colorectal cancer and its “dismal prognosis.”

Global experts gather at Cornell Tech, advancing early detection and survival in pancreatic cancer fight

Newest Carebox Connect Clinical Trial Sponsor Website Helps Mirati Therapeutics Deliver on Its Commitment to Patient-Centricity

Partnership extends capability for trial imaging integration to Florence Healthcare’s 18,000 activated clinical trial sites.

New biologics outsourcing solution provider leverages proven track record of Tanvex BioPharma USA Inc. to help early-stage companies bring mammalian and microbial derived biologics from concept to commercialization.

THANC Guide resource center for thyroid, head and neck cancer patients will now feature Carebox Connect for clinical trial search and matching.

The Oct. 2-3 hybrid workshop will bridge the gap between critical stakeholders to pinpoint today's challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.

Amelia™-1 Study is testing if evexomostat can improve patients' safety and clinical response to a PI3K inhibitor plus an estrogen receptor degrader. Evexomostat, a novel MetAP2 inhibitor, controlled PI3K-induced hyperglycemia in the first study patient, consistent with pre-clinical data. Further, ctDNA data shows no evidence of residual PIK3CA mutation in blood after 6 weeks of treatment.

Rapid NSCLC Biomarker Test already demonstrated its significant impact and clinical benefits as part of a lung cancer clinical study.

Making an impact to support the fight against breast cancer.

Leveraging AI-based molecular profiling from a digitized biopsy image to enable physicians to gain immediate oncology intelligence.

The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report.

Carebox to help LCRF advance lung cancer research by making it easier and more effective for patients, caregivers and healthcare professionals to identify relevant lung cancer trials.

A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patients

CA CURE - its FY23 campaign - was the biggest in its 60-year history and will continue in the coming year.

Card's 18-year journey begins with cancer survivor Tyler Gressle's Make-A-Wish Foundation request and concludes with next week's Beckett/eBay/Collectable auction

Pilot of EHR-embedded clinical trial matching to enhance diversity in cancer research set to begin at two hospital systems in Texas and West Virginia.

AdMeTech Foundation's 14th Annual Prostate Cancer Awareness Day Highlights Massachusetts Model of National Leadership in Public Awareness, Education, Research and Clinical Equity

All-new Yunuverse cloud community capabilities, now standard on the Yunu platform, make it possible for over 1,000 on-demand specialty-trained radiologists, technologists, and study staff to be invited and instantly participate in any of the 4,000 in-flight imaging clinical trials running on the system today. Cancer centers may now extend the reach of trial programs to satellite sites and imaging centers, improving patient access to sophisticated oncology trials.